FDA Commissioner Puts Branded Companies on Notice

In a statement dated May 17, 2018, FDA Commissioner Scott Gottlieb, MD, discussed the steps the agency is taking to improve competition in the drug market and, therefore, improve the public s access to affordable medications. One step in particular is addressing the actions some branded companieOriginal Article